The time course of alpha 2-plasmin inhibitor and plasmin-alpha 2-plasmin inhibitor complex levels in patients with traumatic brain injury
- PMID: 40131499
- PMCID: PMC11937101
- DOI: 10.1007/s00701-025-06496-6
The time course of alpha 2-plasmin inhibitor and plasmin-alpha 2-plasmin inhibitor complex levels in patients with traumatic brain injury
Abstract
Background: In its acute phase, traumatic brain injury (TBI) is notable for disturbances in the coagulation/fibrinolysis system. Plasmin, alpha 2-plasmin inhibitor (α2-PI), and their complex (plasmin-α2-PI complex [PIC]) are important components of the coagulation-fibrinolytic system, but their time courses in the acute phase of TBI and their association with long-term prognosis are unknown.
Methods: We conducted a retrospective analysis of 84 consecutive patients with isolated TBI, during which plasma α2-PI and PIC levels were measured at the time of arrival, as well as at 3, 6, and 12 h, and on days 1, 3, and 7 post-injury. Differences in plasma α2-PI and PIC levels between the good outcome group (extended Glasgow Outcome Scale [GOS-E] of 5-8 at 6 months post-injury) and the poor outcome group (GOS-E of 1-4 at 6 months post-injury) were analyzed using a generalized linear mixed model (GLMM). The hematoma volume of the initial CT scan upon admission and the follow-up CT scan was evaluated using CT volumetry, and then the relationship between changes in hematoma volume and plasma levels of α2-PI and PIC at admission was examined.
Results: Abnormally high plasma PIC levels were observed at admission in 97.6% of the patients. In the GLMM adjusted for covariates, the poor outcome group had significantly lower plasma α2-PI activity from admission to 3 days post-injury and significantly higher plasma PIC levels from admission to 6 h post-injury compared to the good outcome group. A negative correlation was found between α2-PI activity at admission and changes in hematoma volume (Spearman's correlation coefficient, r = - 0.587, p = 0.001).
Conclusions: These findings suggest that plasmin was activated and fibrinolysis enhanced immediately after injury in most patients, while in a subset of patients, hematoma expansion due to the suppression of fibrinolytic inhibition by α2-PI negatively affected the outcome.
Keywords: Alpha-2-antiplasmin; Blood coagulation disorders; Fibrinolysis; Prognosis; Traumatic brain injury.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Central Ethics Committee of Nippon Medical School (Approval #M-2021–025, dated 16 February 2022) and the Ethics Committee of Kawaguchi Municipal Medical Center (Approval #2021–35, dated 7 March 2022). Consent to participate: This study was a retrospective study that used only information such as medical records and did not involve any invasion or intervention, therefore the requirement for obtaining informed consent was waived. Consent to publish: This study was a retrospective study that used only information such as medical records and did not involve any invasion or intervention, therefore the requirement for obtaining informed consent was waived. Competing interests: The authors declare no competing interests.
Figures
References
-
- Allard CB, Scarpelini S, Rhind SG, Baker AJ, Shek PN, Tien H, Fernando M, Tremblay L, Morrison LJ, Pinto R, Rizoli SB (2009) Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage. J Trauma 67:959–967 - PubMed
-
- Association for the Advancement of Automotive Medicine (1998) The Abbreviated Injury Scale (AIS) 1998 Revision. Des Plaines, Illinois
-
- Brenner A, Belli A, Chaudhri R, Coats T, Frimley L, Jamaluddin SF, Jooma R, Mansukhani R, Sandercock P, Shakur-Still H, Shokunbi T, Roberts I, CRASH-3 trial collaborators (2020) Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial. Crit Care 24:560
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
